Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Baik Brian Seung Won(백승원), Chairman & CEO. Director active across 2 companies, notably 케이엠제약. Aggregated, 11 reports have been logged. Activity tracked since 9 March 2026. The latest transaction was disclosed on 15 April 2026 (Purchase). Regulator: DART (FSS). All data is free.
Companies and markets linked to Baik Brian Seung Won(백승원)
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
BAIK BRIAN SEUNG WON is the Chairman & CEO of KM Pharmaceutical. He is responsible for the strategic direction of the company and the management of daily operations. With his experience, BAIK BRIAN SEUNG WON plays a key role in strategic decision-making and defining the company's long-term vision.